calendar
9 catalysts · 3 phase 2 completion · 3 phase 2 initiation · 2 phase 1 completion · 1 phase 3 completion
next 91 dayslessmore
MonWedFri
9 catalysts · 3 phase 2 completion · 3 phase 2 initiation · 2 phase 1 completion · 1 phase 3 completion
Therapy area: Gastrointestinal, Oncology. Indication: Bile Duct Cancer (Cholangiocarcinoma), Hepatocellular Carcinoma, Liver Cancer, Liver Cirrhosis, Metastatic Liver Cancer
Therapy area: Oncology. Indication: Non-Small Cell Lung Cancer, Solid Tumor
Therapy area: Oncology. Indication: Pancreatic Cancer
Therapy area: Oncology. Indication: Non-Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma
Therapy area: Oncology. Indication: Non-Small Cell Lung Cancer
Therapy area: Oncology. Indication: Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer), Solid Tumor
Therapy area: Oncology. Indication: Solid Tumor
Therapy area: Oncology. Indication: Metastatic Pancreatic Cancer, Pancreatic Cancer
Therapy area: Oncology. Indication: Nasopharyngeal Cancer